Brazil vs Zambia: HIV/AIDS deaths averted by antiretroviral therapy
Brazil
49,655 deaths
in 2024
Zambia
76,693 deaths
in 2024
Brazil rank
10th
Zambia rank
7th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Brazil
- Zambia
How they compare
Zambia currently reports 76,693 deaths against 49,655 deaths in Brazil, a difference of 27,038 deaths.
That makes Zambia's figure about 1.5 times Brazil's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Zambia ahead.
Brazil ranks 10th and Zambia ranks 7th of 157 countries.
Across the 4 decades both report, Brazil averaged higher in 2 and Zambia in 2.
Head to head by decade
| Decade | Brazil | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4,547 deaths | 0 deaths | 4,547 deaths | Brazil |
| 2000s | 15,777 deaths | 13,774 deaths | 2,003 deaths | Brazil |
| 2010s | 28,138 deaths | 53,855 deaths | 25,717 deaths | Zambia |
| 2020s | 47,798 deaths | 72,723 deaths | 24,925 deaths | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Brazil or Zambia?
- Zambia, at 76,693 deaths against 49,655 deaths in Brazil as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Brazil and Zambia?
- 27,038 deaths, with Zambia ahead.
- How many years of comparable data are there for Brazil and Zambia?
- 35 years are reported by both, from 1990 to 2024.
- How do Brazil and Zambia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Brazil ranks 10th and Zambia ranks 7th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.